# 該公司必須至少被這五項評級中的四項涵蓋，方可進行計算。

*biotech · news · 2026-03-25 · MarketScreener*

## Key points

- Trader 超級評級使用 4 個月的每股盈餘修正，而非像 Investor 評級採用年度修正。
- Investor 超級評級獨特地將基本面與 1 年期每股盈餘修正納入權重計算。
- Global 綜合評級要求至少涵蓋五個特定類別中的四個，方可進行計算。
- Quality 綜合評級僅在三項指標中至少有兩項被涵蓋時才會計算。

Trader This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Investor This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Global This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions. Quality This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

[Read the full story on MarketScreener](https://www.marketscreener.com/news/sarepta-announces-first-clinical-data-from-sirna-pipeline-targeting-fshd1-and-dm1-ce7e5ed3da8cf32d)

---

Canonical: https://newsio.io/zh-TW/n/1829c57d-185c-445c-a279-93b87f2b98b7/
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works